Ordinary Shares |
Deferred Shares |
Share Price |
Total consideration |
||||||||||||||
Number | Number | £ | £’000 | ||||||||||||||
2015 | |||||||||||||||||
As at 1 January 2015 | 27,794,258 | 1,000,001 | 32,000 | ||||||||||||||
24 April 2015 | Exercise of employee share options | 16,500 | - | 0.00005 | - | ||||||||||||
25 September 2015 | Exercise of employee share options | 10,000 | - | 0.00005 | - | ||||||||||||
4 December 2015 | Share issue on acquisition of DARA BioSciences, Inc. | 5,422,028 | - | 2.63 | 14,240 | ||||||||||||
23 December 2015 | Deferred consideration re: acquisition of Q Chip Limited | 224,718 | - | 2.67 | 600 | ||||||||||||
As at 31 December 2015 | 33,467,504 | 1,000,001 | 46,840 | ||||||||||||||
2016 | |||||||||||||||||
1 July 2016 | Deferred consideration re: acquisition of Q Chip Limited | 74,908 | - | 2.67 | 200 | ||||||||||||
31 October 2016 | Placing and Open Offer (costs shown in note 17) | 15,157,044 | - | 1.10 | 16,673 | ||||||||||||
As at 31 December 2016 | 48,699,456 | 1,000,001 | 63,713 | ||||||||||||||
2017 | |||||||||||||||||
19 May 2017 | Share issue to SIPP trustee (see note 28) | 20,000 | - | 0.00005 | 1 | ||||||||||||
16 October 2017 | Placing and Open Offer (shown in note 17) | 12,314,679 | - | 0.5 | 6,157 | ||||||||||||
7 November 2017 | Share issue to SIPP trustee (see note 28) | 50,000 | - | 0.00005 | 3 | ||||||||||||
As at 31 December 2017 | 61,084,135 | 1,000,001 | 69,874 |